Candriam Equities L Biotechnology Class R USD CapRegister to Unlock Ratings |
Performance History | 30/04/2022 |
Growth of 1,000 (GBP) | Advanced Graph |
![]() | Fund | -5.0 | 30.8 | 16.5 | -1.0 | -6.4 |
![]() | +/-Cat | 3.0 | 10.6 | -9.5 | 8.0 | 10.1 |
![]() | +/-B’mrk | -1.8 | 10.5 | -6.1 | -1.9 | 7.6 |
Category: Sector Equity Biotechnology | ||||||
Category Benchmark: NASDAQ Biotechnology TR USD |
Key Stats | ||
NAV 24/05/2022 | USD 202.50 | |
Day Change | -1.46% | |
Morningstar Category™ | Sector Equity Biotechnology | |
ISIN | LU0942225912 | |
Fund Size (Mil) 24/05/2022 | USD 1438.36 | |
Share Class Size (Mil) 24/05/2022 | USD 137.06 | |
Max Initial Charge | 3.50% | |
Ongoing Charge 18/02/2022 | 1.10% |
Morningstar Research |
Analyst Report |
A growing team of highly qualified biotechnology experts led by one of the industry’s most seasoned investors in the field and a proven process give this fund an edge. The fund’s cheapest share classes receive a Morningstar Analyst Rating of... |
Click here to read this analyst report on the underlying fund. |
Morningstar Pillars | |
---|---|
People | Above Average |
Parent | Average |
Process | Above Average |
Performance | |
Price |
Investment Objective: Candriam Equities L Biotechnology Class R USD Cap |
The objective of the sub-fund is to use discretionary management to benefit from the performance of the market in global equities of companies from the biotechnology sector, and to outperform the benchmark. This sub-fund enables shareholders to invest in a portfolio of global equities in the biotechnology sector. The assets will be invested principally in the equities of companies operating in this sector. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Rudi Van den Eynde 06/04/2000 | ||
Servaas Michielssens 01/01/2019 | ||
Inception Date 08/11/2013 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
NASDAQ Biotechnology TR USD | NASDAQ Biotechnology TR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Candriam Equities L Biotechnology Class R USD Cap | 31/03/2022 |
|
|
Top 5 Holdings | Sector | % |
![]() | ![]() | 6.47 |
![]() | ![]() | 5.62 |
![]() | ![]() | 5.49 |
![]() | ![]() | 5.41 |
![]() | ![]() | 3.40 |
![]() | ||
![]() ![]() ![]() | ||
Candriam Equities L Biotechnology Class R USD Cap |